Inflammatory Bowel DiseaseRichard P. MacDermott, William F. Stenson |
From inside the book
Results 1-3 of 80
Page 25
... patients with AS ranges from 1 % to 25 % , with most in the range 1 % to 6 % , and the frequency of arthritis in UC patient series ranges from zero to 22 % , with most in the range 2 % to 15 % . Among case series of CD patients , the ...
... patients with AS ranges from 1 % to 25 % , with most in the range 1 % to 6 % , and the frequency of arthritis in UC patient series ranges from zero to 22 % , with most in the range 2 % to 15 % . Among case series of CD patients , the ...
Page 407
... patients with Crohn's dis- Most patients have modest elevations in serum alkaline phospha- tase . 16 The lesions may be located in the portal tracts or lobules and the gran- ulomata may coexist with other hepatic disease.10 The ...
... patients with Crohn's dis- Most patients have modest elevations in serum alkaline phospha- tase . 16 The lesions may be located in the portal tracts or lobules and the gran- ulomata may coexist with other hepatic disease.10 The ...
Page 539
... patients in the United Kingdom and Ireland who underwent 100 courses of HPN during 10 years . " Indications for starting therapy were short bowel syndrome ( SBS ) in 60 patients , enteric fistula in 29 patients , and exacerbations of ...
... patients in the United Kingdom and Ireland who underwent 100 courses of HPN during 10 years . " Indications for starting therapy were short bowel syndrome ( SBS ) in 60 patients , enteric fistula in 29 patients , and exacerbations of ...
Other editions - View all
Common terms and phrases
abnormalities acid action activity addition agents alterations antibodies antigens appear associated bacterial blood cause chronic Clin clinical colonic compared complement complex component Crohn's disease cytokines cytotoxic decreased defect determined diarrhea effects enhanced epithelial cells epithelium et al evidence expression factor findings function Gastroenterology genes genetic granulomas growth human immune immune response Immunol immunologic important incidence increased induced infection inflammation inflammatory bowel disease inhibition initially injury intestinal involved isolated lamina propria lesions leukocyte levels lymphocytes macrophages markers mast cells mechanisms mediators mononuclear mucin mucosal Nature neutrophils normal observed occur patients population possible potential present production prostaglandin protein rates recent receptor regulation relatives release reported response risk role schistosomiasis secretion secretory serum shown specific stimulation studies suggest T-cell tissue ulcerative colitis vitro